Microwave until hot, about 1.5 - 2 minutes
BMC Med Genet 15:75 Longo N (2016) Primary carnitine deficiency and newborn screening for disorders of the carnitine cycle
Early Research in Autoimmune Disease & Fibromyalgia What It Shows and Why Its Limited Fibromyalgia: Early Signals, No Conclusions Some observational reports describe symptom improvements (pain, fatigue, opioid use) in people taking GLP-1 medications, but limitations are consistent: non-randomized design, small samples, and confounding from weight loss, sleep, and metabolic improvements
An evolving body of evidence shows that weight reduction improves health outcomes beyond its effect on intermediary CVD risk factors
Quick Answer: GLP-1 receptor agonists may influence substance use behaviors through effects on brain reward circuits, but they currently have no FDA approval for treating substance use disorders